NCT00005599View on ClinicalTrials.gov

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

February 29, 2000

Study Completion Date

August 31, 2004

Conditions

Esophageal CancerGastric Cancer

Interventions

DRUG

bryostatin 1

DRUG

paclitaxel

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

10467

Albert Einstein Clinical Cancer Center, The Bronx

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005599 - Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer | Biotech Hunter | Biotech Hunter